Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-Antibodies & Recombinant Proteins-Other Fusion Proteins-Lerodalcibep
Lerodalcibep

Chemical Structure : Lerodalcibep

CAS No.:

Lerodalcibep (LIB 003)

Catalog No.: PC-38829Not For Human Use, Lab Use Only.

LIB003 (Lerodalcibep) is an engineered PCSK9 protein inhibitor for the treatment of hypercholesterolemia. Anti-(human proprotein convertase subtilisin/kexin type 9), derived from human tenth fibronectin type III domain, fused via peptidyl linker (97GSGSGS102) to human serum albumin (103-687), variant (C34>A136), produced in Chinese hamster ovary (CHO) cells.

Packing Price Stock Quantity
1 mg Get quote
5 mg Get quote
10 mg Get quote
25 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

LIB003 (Lerodalcibep) is an engineered PCSK9 protein inhibitor for the treatment of hypercholesterolemia. Anti-(human proprotein convertase subtilisin/kexin type 9), derived from human tenth fibronectin type III domain, fused via peptidyl linker (97GSGSGS102) to human serum albumin (103-687), variant (C34>A136), produced in Chinese hamster ovary (CHO) cells.

Physicochemical Properties

M.Wt
Formula
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

References

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: